Data Deep Dive: CAR T-Cell Therapy for Large B-Cell Lymphoma

Summary

Tune into our first episode in the Avalere Health Essential Voice series focused on disease education. In this segment, our experts discuss recent research that, using Medicare fee-for-service claims data, studied healthcare utilization, costs, outcomes, and other characteristics of patients who received CAR T-cell therapy for large B-cell lymphoma.

To listen to this video as a podcast or read the transcript, please visit our podcast page.

On the Record: Health Plan and Provider Perspectives Video Series Federal and state policymakers are actively shaping health coverage and access, and we’re here to explain exactly what these changes mean for plans and providers.
Watch the video series ​ Connect with the team directly
From beginning to end, our team synergy
produces measurable results. Let's work together.

Sign up to receive more insights about Cell and Gene Therapy
Please enter your email address to be notified when new Cell and Gene Therapy insights are published.

Back To Top